ArticleThe Journal of clinical investigation2021

A therapeutic cancer vaccine delivers antigens and adjuvants to lymphoid tissues using genetically modified T cells.

Joshua R Veatch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.